Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
United BioPharma's Study Reveals New Class of Monoclonal Antibody for Effective Relief of Urticaria Symptoms 2022-08-05 20:45
Yiling's Lianhua Health Products Well-received: CICPE 2022-08-05 15:54
111 to Announce Second Quarter 2022 Unaudited Financial Results on August 25, 2022 - Conference Call to Follow 2022-08-05 14:26
Innovent Biologics and Sanofi Enter Strategic Collaboration to Accelerate Development of Oncology Medicines and Expand Presence in China 2022-08-04 23:30
Ascletis Announces IND Filing of Oral RdRp Inhibitor ASC10 for COVID-19 Accepted by China NMPA 2022-08-04 08:10
ST Pharm Presents Phase 1 Clinical Trial Results of HIV Treatment Candidate at AIDS 2022 2022-08-03 20:00
ProfoundBio Receives FDA "Study May Proceed" Letter for PRO1184, a Folate Receptor Alpha-Directed ADC with a Topoisomerase 1 Inhibitor Payload, and Welcomes Naomi Hunder, M.D., as Chief Medical Officer 2022-08-03 20:00
Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of KX-826 for Treatment of Androgenetic Alopecia in the US 2022-08-03 19:38
Ascletis Announces FDA Clearance of Oral RdRp Inhibitor ASC10 to Conduct a Randomized, Placebo Controlled Phase Ib Study in Mild-to-Moderate COVID-19 Patients 2022-08-03 16:50
Approval Of The Comparative Study Between ReCOV And mRNA Vaccines By FDA In The Philippines 2022-08-03 13:09
Antengene Announces First Patient Dosed in the PROBE-CN Study of ATG-101 (PD-L1/4-1BB Bispecific Antibody) for the Treatment of Solid Tumors and Non-Hodgkin Lymphoma 2022-08-03 08:30
Sciwind Biosciences Announces Positive Topline Results from 20-week Phase 2 Clinical Trial of XW003 (Ecnoglutide), a novel long-lasting GLP-1 analogue, in Adult Patients with Type 2 Diabetes in China 2022-08-03 08:00
Lynk Pharmaceuticals Announces IND Approval of LNK01004 for Atopic Dermatitis in China 2022-08-03 08:00
Ablaze Pharma Aligned The Strategic Agreement With Wenjiang District Government of Chengdu to Build-up the Innovative R&D and Manufacturing Center for Targeted Radiopharmaceutical Therapies 2022-08-03 08:00
Context Therapeutics and The Menarini Group Announce Clinical Trial Collaboration and Supply Agreement to Evaluate ONA-XR and Elacestrant Combination 2022-08-02 22:49
GenKOre develops hypercompact base editing system 2022-08-02 22:44
Metabolon Awarded ISO 9001:2015 Recertification 2022-08-02 20:57
CARsgen Appoints Dr. Hua Jiang as Executive Director 2022-08-02 20:50
Ablaze Pharma Aligned The Strategic Agreement With Wenjiang District Government of Chengdu to Build-up the Innovative R&D and Manufacturing Center for Targeted Radiopharmaceutical Therapies 2022-08-02 20:39
Chime Biologics Received Commercial Manufacturing License Indicating the Kick-off into the Era of Commercial Production 2022-08-02 20:15
1 122 123 124 125 126 377